We are Medivolve.
A healthcare technology and services company that seeks out disruptive technologies, ground-breaking innovations and exclusive partnerships to transform human health management.
Born out of the Covid-19 pandemic and the urgent need to address gaps in the nation’s fragmented, overly complex and expensive health system, our model is poised to create a full-circle solution that makes it easier and faster to identify, treat, and possibly prevent medical issues. Powered by AI, our technology platform works together with our diagnostic labs, pharmacies and physicians to close the gap between diagnosis and treatment, empower people with more control over their personal health and achieve a continuity of care never seen before.
What we do
Our team is built to search for challenges, develop solutions, and solve the crisis at hand through strategic investment of human and financial resources.
Built for Transformation
We are building a med-tech platform to not only change the way we approach global health crises, but the future of human health management.
Create Healthier Lives
Our model aims to create a full-circle healthcare solution that closes the gap between diagnosis and treatment.
Inspire the New Future of Healthcare
We are striving to achieve a continuity of care never seen before.
Our advantage comes in the form of proprietary knowledge and experience.
We are comprised of a team of renowned global medical and business advisors who are committed to helping fulfill Medivolve’s mission of searching for and investing in breakthrough sciences, technologies, research, and resolutions to empower the betterment of mankind.
This braintrust includes prominent Stanford neurologist and immunologist Dr. Lawrence Steinman as well as Dr. Glenn Copeland, one of North America’s most prominent orthopedic treatment and sports medicine specialists. Through our panel of industry specialists, thought leaders, influencers, and opinion makers, Medivolve has also developed a proprietary strategy to capitalize on high-margin opportunities across: the prevention, detection, and treatment of COVID-19, and beyond.
We invest in developing and delivering solutions to challenge that require velocity without compromise.
We measure and monitor the return on investment to ensure betterment metrics are a strategic priority.
We mandate that following a purposeful return on investment, bandwidth and focus is equally a positive return on investment of resources.
Join Medivolve's Investor Mailing List Today
Stay up to date on the latest developments and breakthroughs.